Service interruption on Monday 11 July from 12:30 to 13:00: all the sites of the CCSD (HAL, Epiciences, SciencesConf, AureHAL) will be inaccessible (network hardware connection).
Skip to Main content Skip to Navigation
Journal articles

Mechanisms of cancer-associated thrombosis

Abstract : Patients with cancer may display many types of hemostatic disorders that significantly contribute to morbidity and mortality in this disease. A complex coagulopathy develops in parallel with malignancy and is characterized by activation of clotting mechanisms to different extent in different patients and in different types of tumor. The pathogenesis of hemostatic alterations in cancer is multifactorial; however, the tumor tissue capacity to interact with and activate the host hemostatic system plays an important role. New molecular pathways of regulation of these properties have been recently demonstrated. Intervention strategies to prevent and treat venous thromboembolism (VTE) in cancer patients have been addressed by large RCTs and guidelines for VTE management have been updated. In this review, we will present an updated overview of the complex coagulopathy associated to malignancy and of recent advances in the thrombotic risk assessment of cancer patients. ; ;; ;
Document type :
Journal articles
Complete list of metadata
Contributor : Annick Prémilleux Connect in order to contact the contributor
Submitted on : Tuesday, June 2, 2020 - 6:39:19 PM
Last modification on : Sunday, June 26, 2022 - 10:24:24 AM

Links full text




Diane Mege, Panicot-Dubois Laurence, Dubois Christophe. Mechanisms of cancer-associated thrombosis. HemaSphere, Lippincott, Williams & Wilkins, 2019, 3, pp.19-21. ⟨10.1097/HS9.0000000000000239⟩. ⟨hal-02737073⟩



Record views